CD44: From diagnosis to therapy in the journey of oral cancer
Highlights: • Advancements in OSCC treatment have not reduced mortality due to challenges in early diagnosis, highlighting the need for prognostic biomarkers. • CSCs in OSCC fuel chemo-radio-resistance, making their targeting crucial. • CD44, a CSC biomarker, drives cancer progression and resistanc...
Saved in:
Main Authors: | Selvaraj Jayaraman, Vishnu Priya Veeraraghavan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Oral Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024003297 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insights of nano drug delivery for cancer immunotherapy: Targeting tumor-associated macrophages in oral squamous cell carcinoma
by: Kalaiselvi Krishnamoorthy, et al.
Published: (2024-06-01) -
NGS revolutionizing oral cancer: From genetic profiling to personalized therapy
by: Gayathri Rengasamy, et al.
Published: (2024-06-01) -
Can vimentin be an emerging early detection molecular biomarker in oral squamous cell carcinoma?
by: Kalaiselvi Krishnamoorthy, et al.
Published: (2024-06-01) -
Advancements in targeted drug delivery: A promising approach in oral cancer treatment
by: Rajkumar Prabhakaran, et al.
Published: (2024-06-01) -
Exosome mediated tailored therapy for oral cancer
by: Gayathri Rengasamy, et al.
Published: (2024-06-01)